Add to that:
16 locations now in total.
Whilst you may not consider the above in itself to be an achievement as such, it shows that the trial is now well underway and why KK is still confident that his target to complete recruitment by the end of the year can be met.
As announced previously, additional countries are yet to follow.
Ann: First Patient Treated in Phase 2 GvHD Trial, page-62
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33236 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 163350 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |